View in EDS HTML Full Text PDF Full Text

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.

Saved in:
Bibliographic Details
Title: Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.
Authors: Huang D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Tran JT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Olson A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Vollbrecht T; Department of Medicine, The University of California San Diego, La Jolla, CA, USA., Tenuta M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Guryleva MV; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Faculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow, Russia., Fuller RP; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA., Schiffner T; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA., Abadejos JR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Couvrette L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Faculty of Science, University of Ottawa, Ottawa, Canada., Blane TR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Saye K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA., Li W; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Landais E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Gonzalez-Martin A; Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain., Schief W; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA., Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. benjamin.murrell@ki.se., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA. burton@scripps.edu., Nemazee D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. nemazee@scripps.edu., Voss JE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu.
Source: Nature communications [Nat Commun] 2020 Dec 07; Vol. 11 (1), pp. 6360. Date of Electronic Publication: 2020 Dec 07.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33288767
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+D%22">Huang D</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tran+JT%22">Tran JT</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Olson+A%22">Olson A</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vollbrecht+T%22">Vollbrecht T</searchLink>; Department of Medicine, The University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tenuta+M%22">Tenuta M</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Guryleva+MV%22">Guryleva MV</searchLink>; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Faculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Fuller+RP%22">Fuller RP</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Schiffner+T%22">Schiffner T</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Abadejos+JR%22">Abadejos JR</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Couvrette+L%22">Couvrette L</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Faculty of Science, University of Ottawa, Ottawa, Canada.<br /><searchLink fieldCode="AU" term="%22Blane+TR%22">Blane TR</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Saye+K%22">Saye K</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Landais+E%22">Landais E</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Martin+A%22">Gonzalez-Martin A</searchLink>; Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Schief+W%22">Schief W</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Murrell+B%22">Murrell B</searchLink>; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. benjamin.murrell@ki.se.<br /><searchLink fieldCode="AU" term="%22Burton+DR%22">Burton DR</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA. burton@scripps.edu.<br /><searchLink fieldCode="AU" term="%22Nemazee+D%22">Nemazee D</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. nemazee@scripps.edu.<br /><searchLink fieldCode="AU" term="%22Voss+JE%22">Voss JE</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2020 Dec 07; Vol. 11 (1), pp. 6360. <i>Date of Electronic Publication: </i>2020 Dec 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33288767
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-020-20304-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6360
    Titles:
      – TitleFull: Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang D
      – PersonEntity:
          Name:
            NameFull: Tran JT
      – PersonEntity:
          Name:
            NameFull: Olson A
      – PersonEntity:
          Name:
            NameFull: Vollbrecht T
      – PersonEntity:
          Name:
            NameFull: Tenuta M
      – PersonEntity:
          Name:
            NameFull: Guryleva MV
      – PersonEntity:
          Name:
            NameFull: Fuller RP
      – PersonEntity:
          Name:
            NameFull: Schiffner T
      – PersonEntity:
          Name:
            NameFull: Abadejos JR
      – PersonEntity:
          Name:
            NameFull: Couvrette L
      – PersonEntity:
          Name:
            NameFull: Blane TR
      – PersonEntity:
          Name:
            NameFull: Saye K
      – PersonEntity:
          Name:
            NameFull: Li W
      – PersonEntity:
          Name:
            NameFull: Landais E
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Martin A
      – PersonEntity:
          Name:
            NameFull: Schief W
      – PersonEntity:
          Name:
            NameFull: Murrell B
      – PersonEntity:
          Name:
            NameFull: Burton DR
      – PersonEntity:
          Name:
            NameFull: Nemazee D
      – PersonEntity:
          Name:
            NameFull: Voss JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 12
              Text: 2020 Dec 07
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1